Schedule 13G ownership disclosure

Immunic Inc

Common Stock, par value $0.0001 per share · CUSIP: 4525EP101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Soleus Private Equity Fund III, L.P.

    Shares: 1,060,457.00 · Class: 1.1%

  • Soleus Private Equity GP III, LLC

    Shares: 1,060,457.00 · Class: 1.1%

  • Soleus PE GP III, LLC

    Shares: 1,060,457.00 · Class: 1.1%

  • Soleus Capital Master Fund, L.P.

    Shares: 519,550.00 · Class: 0.5%

  • Soleus Capital, LLC

    Shares: 519,550.00 · Class: 0.5%

  • Soleus Capital Group, LLC

    Shares: 519,550.00 · Class: 0.5%

  • Soleus Capital Management, L.P.

    Shares: 1,580,007.00 · Class: 1.6%

  • Soleus GP, LLC

    Shares: 1,580,007.00 · Class: 1.6%

  • Guy Levy

    Shares: 1,580,007.00 · Class: 1.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-107607
Form type
SCHEDULE 13G/A
Filer
IMMUNIC, INC.
CIK
CIK 1280776
Filed
Nov 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub